Medtronic, a leading medical device company, is set to report its first-quarter fiscal 2025 earnings on August 20th. While the company faces challenges from rising costs and currency fluctuations, its underlying business remains strong with several growth drivers. This report examines the key factors that will likely influence Medtronic’s Q1 performance.
Starbucks is expected to report its fiscal second-quarter earnings after the bell on Tuesday. Analysts surveyed by LSEG forecast earnings per share of 79 cents and revenue of $9.13 billion. After a weak report last quarter, analysts are not expecting significant improvement in demand until the second half of the fiscal year. The coffee giant has faced challenges with declining traffic to its cafes due to discounting by rivals in China and boycotts by some U.S. consumers. Despite these headwinds, Starbucks remains optimistic and expects sales to rebound. The company is investing heavily in advertising and promoting new seasonal drinks. For fiscal 2024, Starbucks anticipates revenue growth of 7% to 10% and global same-store sales growth of 4% to 6%. The company also expects earnings per share growth of 15% to 20%. Starbucks shares have declined 22% over the past year, with a market value of $100 billion.
Stem (NYSE: STEM) is set to report its highly anticipated Q1 2024 results on Thursday, May 2, post-market. However, analysts are urging caution, citing the company’s restrictive balance sheet and uncertain cash flow projections. Despite its presence in the innovative renewable energy sector, Stem faces challenges in revenue predictability and competitive pressures, suggesting that the risk outweighs the potential rewards.
IBM is set to release its first-quarter earnings report on April 24th, with analysts anticipating earnings per share of $1.59 and revenues of $14.54 billion. While concerns exist about potential weakness in the consulting business, analysts remain optimistic, citing improving macro and IT spending data points. The company’s AI business is expected to be a key focus for investors as enterprises increasingly adopt AI tools to enhance productivity. IBM’s revenue is also likely to benefit from the recent sale of Weather Company assets.
Texas Instruments (TXN) is set to release its first-quarter earnings results on Tuesday, with analysts expecting a decline in earnings per share and revenue compared to the previous year. Despite the expected decrease, the company offers a competitive annual dividend yield of 3.18%. Investors can potentially earn a monthly dividend of $500 by investing approximately $188,598 in the company’s shares or a more modest $100 per month with an investment of around $37,752. Additionally, Evercore ISI Group analyst Mark Lipacis has initiated coverage on Texas Instruments with an Outperform rating and a price target of $213.
Impinj, a leading RFID manufacturer, will report its Q1 earnings tomorrow afternoon. Analysts predict a 14.3% year-over-year revenue decline to $73.58 million, along with adjusted earnings per share of $0.11. While Impinj has historically exceeded expectations, the current market volatility within the semiconductors sector could impact its performance. Investors should also note the recent earnings results of Impinj’s peers, such as SMART (down 26.7%) and Micron Technology (up 57.7%).
Garrett Nelson, a senior equity research analyst at CFRA, provides his expert analysis ahead of Tesla’s highly anticipated quarterly earnings report, which is expected to be released after market close today.
RBC Global Autos Analyst Tom Narayan discusses the recent decline in Tesla’s share price and his expectations for the company’s upcoming earnings report.
Microsoft is set to release its fiscal Q3 2024 earnings after market close on Thursday. Analysts predict earnings per share of $2.83 and revenue of $60.769 billion, indicating year-over-year growth of 15.1% and 15.98%, respectively. Goldman Sachs analysts are optimistic about Microsoft’s ability to scale Gen-AI revenue, drive Azure growth, and continue its earnings outperformance. The company’s 12-month average price target is $478, suggesting a potential 18% stock upside.
